Guo Q et al. found that the methylation status of the FBN1 promoter was a high specific and sensitive biomarker for colorectal cancer, and the detection of hypermethylated FBNI in stool samples was a useful method for colorectal cancer screening [19]. Here, FBN1 is linked to colorectal cancer.